Remi Meds review

What it is

Remi Meds is a direct-to-consumer telehealth platform with a compact menu organised by outcome: Weight Loss (personalised GLP-1 and GLP-1/GIP with B12), Energy + Mood (NAD⁺ injections and NAD⁺ troches), Cardio + Strength (sermorelin injections and sermorelin troches) and Antioxidant (glutathione injections and glutathione troches). It describes itself as a patient-management platform partnering with independent licensed physician networks — not a pharmacy and not a medical provider — and states that payment does not guarantee a prescription will be written or dispensed. It publishes a mailing address at 920 E. Dixie Ave, Suite A, Leesburg, Florida.

How it works

Questionnaire, then a consultation with a provider, then shipment from a partner pharmacy on eligibility, with regular check-ins afterwards. Two disclosures are better than the board norm and one set of details is worse. Better: the FAQ names Strive Pharmacy in Gilbert, Arizona with a street address, phone number and email, and names Beluga Health with its website as the prescribing network — most competitors will not name either. Worse: the site publishes three different phone numbers across its header, footer and contact block, and the contact panel carries an email at rekindlerx.com, a different brand, which suggests shared back-office infrastructure the site does not explain. No medical director, founder or individual physician appears on any public page, and the state position is a bare "we offer nationwide service" with an invitation to contact support if you are unsure — which is not the same as publishing where you are licensed. The FAQ's own line on accreditation is oddly soft, saying it encourages the use of LegitScript or NABP-accredited facilities rather than stating that its partner is one. Billing is described as charged when the medication ships. Note also that its clinical partner, Beluga Health, has been named in reporting as the network behind a number of FDA-warned GLP-1 companies; Remi Meds itself has not been the subject of an FDA warning letter, and the association is worth knowing rather than treating as a verdict.

Pricing transparency

Unusually specific, and that is the reason to look. Sermorelin is $249 a month for 3 ml a week as a starting dose and $349 a month for 9 ml a week, with a sublingual troche form offered alongside. NAD⁺ injections are $349 a month at 10 ml a week, described as a 30-day supply shipped every 30 days. Glutathione is where the discipline slips: the subcutaneous injection is listed at $219 with no billing period stated anywhere on the page, so it is not clear whether that is a month, a vial or a course — ask before ordering, and do not assume monthly. Dosage is stated as set by the licensed provider on medical judgement, so the tier you land on is not yours to choose. On the weight-loss side, GLP-1 runs $249 to $369 a month by dose tier and GLP-1/GIP with B12 runs $349 to $649, fully laid out rather than hidden behind an "as low as" — but those are GLP-1 numbers and are not a peptide price. Shipping is stated as free in one to four days if prescribed.

Branded vs compounded

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Remi Meds states it is not a pharmacy and does not provide medical services directly, names Strive Pharmacy as its partner in the FAQ, and carries a clear non-affiliation disclaimer for the branded GLP-1 trademarks — but compounded sterile preparations are not reviewed by the FDA for purity and potency the way approved drugs are, whoever prepares them. On the evidence, the three wellness molecules diverge sharply. Sermorelin is a growth-hormone-releasing hormone analogue that stimulates the pituitary to release your own growth hormone rather than supplying it exogenously, which preserves the feedback loop injected HGH bypasses; the mechanism is real and well described, and the long-term human outcome data behind the body-composition, sleep and recovery claims stays thin. Its own product page's claim that sermorelin has been "clinically proven to increase HGH levels" is fair as far as it goes — raising GH and IGF-1 is measurable — but a raised hormone level is not the same as a demonstrated clinical outcome, and the page's leap to fat breakdown, muscle growth and bone strengthening runs ahead of the human evidence. Injected and sublingual NAD⁺ have no controlled human outcome trials; oral NR and NMN are the studied forms and what they show is a raised blood NAD⁺ level. Injectable glutathione has essentially no controlled human outcome data behind the brightening, detoxification and immune claims made for it. Individual results vary.

Pros and watch-outs

The evidence behind what Remi Meds prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• Sermorelin: a real GHRH drug, read against the anti-aging pitch

  An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

• Glutathione: the master antioxidant, and where the evidence actually is

  Oral glutathione really does raise your body stores (a 6-month RCT proved it) — but the longevity and detox claims are unproven, skin-lightening is modest, and IV glutathione is the most marketed, least evidenced route. The precursors may be the smarter bet.

How Remi Meds compares

A few alternatives worth a look, depending on what you’re optimizing for.

• RHRxION Health

  A flat NAD⁺ price from a platform that says on the page what the evidence does not support

  See RxION Health →
• REREMEVi

  Choosing between injected, nasal and oral NAD⁺ without the price changing

  See REMEVi →
• RHRevel Health

  Comparing injected against intranasal NAD⁺ at two published prices in one place

  See Revel Health →